EPI-001
≥98%
- Product Code: 86231
CAS:
227947-06-0
| Molecular Weight: | 394.89 g./mol | Molecular Formula: | C₂₁H₂₇ClO₅ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD02683414 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C |
Product Description:
EPI-001 is a compound that has been studied for its potential therapeutic applications, particularly in the field of oncology. It functions as an androgen receptor antagonist, which makes it a candidate for treating prostate cancer. By inhibiting the androgen receptor, EPI-001 can potentially block the growth and proliferation of cancer cells that rely on androgen signaling for their survival. This mechanism is especially relevant in castration-resistant prostate cancer, where traditional hormone therapies are no longer effective. Research is ongoing to explore its efficacy and safety in clinical settings, with the hope of developing it into a viable treatment option for patients with advanced prostate cancer.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | White to Almost white powder to crystal |
| PURITY | 97.5-100 |
| Infrared spectrum | Conforms to Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | $292.78 |
+
-
|
EPI-001
EPI-001 is a compound that has been studied for its potential therapeutic applications, particularly in the field of oncology. It functions as an androgen receptor antagonist, which makes it a candidate for treating prostate cancer. By inhibiting the androgen receptor, EPI-001 can potentially block the growth and proliferation of cancer cells that rely on androgen signaling for their survival. This mechanism is especially relevant in castration-resistant prostate cancer, where traditional hormone therapies are no longer effective. Research is ongoing to explore its efficacy and safety in clinical settings, with the hope of developing it into a viable treatment option for patients with advanced prostate cancer.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :